Ono’s Stock Price Decline on Merck’s KN-189 Success
On April 16, 2018, the topline data for Ono Pharmaceutical Co Ltd (4528 JP) Opdivo and Merck & Co. Inc. (MRK US) Keytruda, both as a...
135 Views
Japan Pharmaceuticals: The Week that Was…
Takeda Pharmaceutical Co Ltd (4502 JP) @ ¥ 4,911/ share (down 24% YTD) implies ~17x (~30% discount to industry average) our FY19e core EPS of ¥...
118 Views
Ono’s Stock Price Decline on Merck’s KN-042 Success
Merck & Co. (NYSE: MRK), on April 09, 2018, announced Keytruda’s (pembrolizumab) success in improving overall survival (OS) as 1L treatment in...
123 Views
Japan Pharma - Drug Price Revision in April 2018
Japan, after the US and China, is the world’s third largest pharma industry, worth ~$70b in 2016. However, according to research and consulting...
265 Views
Cyberdyne (7779) - Is This the Death-Knell for Short Sell Reports on Japanese Stocks?
Shares in Cyberdyne (7779 JP) have surged following the news that it has gained approval in the US for its "Medical HAL" exoskeleton suit to be...
409 Views